OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States.
OmniComm Systems announced that it has signed an agreement with one of the top five medical research universities in the United States. The university plans to use OmniComm’s TrialMaster EDC and related services to conduct a series of clinical studies over a period of five years.
Read the full release here
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.